Eneda Hoxha
Vice President, Intellectual Property & Business Development, & Head of Machine Learning
Professional Overview
Eneda Hoxha is a seasoned legal and technology professional with over a decade of experience in the life sciences industry. As the Vice President of Intellectual Property & Business Development, and Head of Machine Learning at ReCode Therapeutics, she leverages her expertise in intellectual property law, business strategy, and cutting-edge technology to drive innovation and growth within the company.
Experience Summary
Current Role
In her current role, Eneda is responsible for overseeing the company's intellectual property portfolio, leading business development initiatives, and spearheading the application of machine learning for drug discovery and development. She has played a pivotal role in securing key strategic partnerships and collaborations, further strengthening ReCode Therapeutics' position as a leader in the field of genetic medicine.
Career Progression
Prior to her current position, Eneda served as the Sr. Director of Intellectual Property at ReCode Therapeutics, where she was instrumental in building and managing the company's extensive patent portfolio. Before joining ReCode, she held roles as an Associate at several prestigious law firms, including Latham & Watkins, Durie Tangri LLP, and Morrison & Foerster LLP, where she gained deep expertise in intellectual property law and business strategy.
Eneda's early career experiences include roles as a Scientist at Cellular Dynamics International and as an Innovation 2 Commercialization Fellow at Northwestern University, where she honed her skills in translating scientific breakthroughs into commercial applications.
Academic Background
Eneda holds a Juris Doctor degree from the University of California, Berkeley - School of Law, where she currently serves as a Lecturer, sharing her extensive knowledge and insights with the next generation of legal professionals.
Areas of Expertise
- Intellectual property strategy and management
- Business development and strategic partnerships
- Application of machine learning in drug discovery and development
- Translating scientific innovations into commercial success
Professional Impact
Eneda's contributions have had a significant impact on the life sciences industry. She has been instrumental in securing numerous patents and strategic alliances that have strengthened ReCode Therapeutics' position as a leader in the field of genetic medicine. Additionally, her pioneering work in the application of machine learning has accelerated the company's drug discovery and development processes, leading to groundbreaking advancements in personalized therapeutics.
Conclusion
With her exceptional legal expertise, business acumen, and technical prowess, Eneda Hoxha is poised to continue driving innovation and growth within the life sciences industry. Her ability to navigate the complex landscape of intellectual property, business strategy, and emerging technologies positions her as a valuable asset to ReCode Therapeutics and the broader scientific community.
